Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells

Cancer Research

Volumn 60, Issue 17, 2000, Pages 4838-4844

  Tanaka, F ^a   Hashimoto, W ^a   Okamura, H ^a   Robbins, P D ^a   Lotze, M T ^a   Tahara, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 2;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; COLON ADENOCARCINOMA; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DOSE RESPONSE; FIBROSARCOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ADENOCARCINOMA; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN PRESENTATION; COCULTURE TECHNIQUES; COLONIC NEOPLASMS; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; FIBROSARCOMA; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-18; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, SCID; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0034282529     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Cloning of a new cytokine that induces IFN-γ production by T cells
2. A novel costimulatory factor for γ interferon induction found in the livers of mice causes endotoxic shock
3. Development of CD8 + effector T cells is differentially regulated by IL- 18 and IL- 12
4. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells
5. Differential antitumor effects of administration of rIL-18 or rIL-12 are mediated primarily by Fas-Fas Ligand- and perforin-induced tumor apoptosis, respectively
6. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein
7. IFN-γ-inducing factor/IL-18 administration mediates IFN-γ- and IL-12-independent antitumor effects
8. In vivo antitumor effects of murine interferon-γ-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites
9. Potent antitumor effects mediated by local expression of the mature form of the interferon-γ inducing factor, interleukin-18 (IL-18)
10. Defective NK cell activity and Th1 response in IL-18-deficient mice
11. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB
12. The dendritic cell system and its role in immunogenicity
13. Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro
14. Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12
15. Isolation and flow cytometric analysis of the free lymphomyeloid cells present in murine liver
16. Selective in vitro of T lymphocytes from normal human bone marrows
17. In vitro growth of cytotoxic human lymphocytes. Use of T cell growth factor (TCGF) to clone human T cells
18. In vitro growth of cytotoxic human lymphocytes. The preparation of lectin-free T cell growth factor (TCGF) and an analysis of its activity
19. Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma
20. Human 1L-7: A novel T cell growth factor
21. IL-10, a novel growth cofactor for mature and immature T cells
22. Interleukin-12 promotes the ploriferation and cytolytic maturation of immune effectors: Implications for the immunotherapy of cancer
23. Accessory function for NK1.1+ natural killer cells producing interferon-gamma in xenospecific cytotoxic T lymphocyte differention
24. A distinct IL-18-induced pathway to fully activate NKT lymphocytes independently from TCR engagement
25. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
26. Therapy of murine tumors with rumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines
27. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes
28. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo
29. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors
30. Dentritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo
31. Processing of bacterial antigens for peptide presentation on MHC class I molecules
32. Consequences of cell death. Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
33. Dendritic cells directly trigger NK cells function: Cross-talk relevant in innate anti-tumor responses in vivo
34. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: Critical role in migration from the tumor site to draining lymph nodes